Indonesia Dietary Supplements Market

The Indonesia dietary supplements market is expected to exhibit a CAGR of 7.7% during the forecast period, owing to the rising health awareness. For instance, Indonesia is influenced by malnutrition and chronic diseases, especially in children and women. According to World Health Organization (WHO) survey in Indonesia, about 29% of deaths are caused by maternal & perinatal and nutritional deficiencies. Chronic diseases accounted for 61% of deaths at all age levels in Indonesia. Also, the prevalence of overweight, which is an important cause of chronic diseases is projected to increase over the next 10 years in both men and women. Dietary supplements have already proven their importance in curing malnutrition. Doctors also recommend extra nutrition supplements along with a daily diet in case of nutritional deficiencies. Though there is no strong evidence-based data for the efficacy of multivitamins/ mineral supplementation in the primary prevention of chronic diseases, in some cases, dietary supplements are found to be effective. Owing to such prime factors, Indonesia is expected to grow at a significant rate in the dietary supplements market.

On the basis of form, the liquid segment is expected to generate significant revenue till the end of the forecast period. Supplements such as vitamins or minerals are suspended in a liquid (water or alcohol based). This form of supplements is usually used for people suffering from dysphagia. For medicinal supplements for children, liquid form is preferred. In few cases it is flavored to mask the taste of the supplement. Supplements in liquid form have a low shelf life and must be consumed within a stipulated timeframe after opening of the packaging.

Key features of the study

• This report provides in-depth analysis of the dietary supplements market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021 - 2028), considering 2020 as the base year
• It elucidates potential revenue opportunities across different segments and explains an attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global dietary supplements market based on the following parameters – company overview, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include PT Darya-Varia Laboratoria Tbk, Citra Nusa Insan Cemerlang PT, Sido Muncul PT, The Tempo Group, Bayer AG, BASF SE, Pfizer Inc., Nature’s Sunshine Products, Inc., Amway and Glanbia PLC.
• Insights from this report would allow marketers and management authorities of companies to make an informed decision regarding future products launches, technology up-gradation, market expansion, and marketing tactics
• The Indonesia dietary supplements market report caters to various stakeholders in this industry including investors, suppliers, dietary supplements manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Indonesia dietary supplements market

Detailed Segmentation:

• Indonesia Dietary Supplements Market, By Supplements:
  • Vitamins
  • Minerals
  • API’s
  • Amino Acid
  • Enzymes
  • Botanicals
  • Carotenoids
  • Others
• Indonesia Dietary Supplements Market, By Application:
  • Sports Nutrition
  • Medicinal Supplements
  • Personal Care Supplements
  • Others
• Indonesia Dietary Supplements Market, By Form:
  • Tablets
  • Capsules
  • Powder
  • Liquid
  • Soft Gel
  • Gel Caps
• Indonesia Dietary Supplements Market, By Age Demographic:
  • Infant
  • Children
  • Adult
  • Pregnant Women
  • Geriatric Population
• Company Profiles
  • ADM*
    • Company Overview
    • Product Portfolio
    • Key Strategies
    • Recent Developments
    • Future Plans
  • PT Darya-Varia Laboratoria Tbk
  • Citra Nusa Insan Cemerlang PT
  • Sido Muncul PT
  • The Tempo Group
  • Bayer AG
  • BASF SE
  • Pfizer Inc.
  • Nature’s Sunshine Products, Inc.
  • Amway
  • Glanbia PLC

 “*” marked represents similar segmentation in other categories in the respective section.